Clinical Trial Update: Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing low-dose supplemental external radiation with Pd-103 versus Pd-103 alone in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pd-103 (Palladium-103)

Snippet

Sponsor: Schiffler Cancer Center | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED